Clinique dentaire
Strasbourg, 67000, France
Location status: Recruiting
NCT Number: NCT06483646
Halitosis or bad breath is a problem affecting 30% of the world's population. There are many causes, and oral pathologies, including periodontitis, are the main etiology. In order to make a diagnosis, a clinical interview is necessary to distinguish true halitosis from psychological halitosis. In addition, a measurement of volatile sulfur compounds (VSC), the main molecules involved in bad breath, is necessary. This is done during the consultation by measuring the concentration of VSCs in exhaled air. However, few private practices or hospitals have the necessary equipment to measure VSC. As a result, patients are often obliged to travel long distances to obtain a consultation including this specific VSC analysis. The aim of this study is to evaluate the stability of VSC values obtained in gaseous samples up to 7 days after sampling, in order to assess the clinical relevance of analyzing samples at a distance from sampling. The clinical aim is to determine whether self-sampling by the patient at home and extemporaneous analysis could be considered in the diagnosis of halitosis.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Strasbourg, 67000, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the subject is asked to aspirate the gaseous contents of his oral cavity using a 1ml plastic syringe.
Time frame: Analysis will be made at Day 0 and Day 7
University Hospital, Strasbourg, France
Other
Evaluation of the Stability of Volatile Sulfur Compounds in Gas Samples for Halitosis Diagnosis
Acronym: HALITOSIX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07463859
Diabetes Mellitus, Diabetes Mellitus, Type 2
Bauru, São Paulo, Brazil
View Trial DetailsNCT06091228
Halitosis, Mouth Diseases
Leuven, Belgium
View Trial DetailsNCT01793168
1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V
Sioux Falls, South Dakota, United States
View Trial DetailsNCT06900881
Halitosis, Mouth Diseases
Baghdad, Iraq
View Trial Details